Next Article in Journal
Different Strategies to Overcome Resistance to Proteasome Inhibitors—A Summary 20 Years after Their Introduction
Previous Article in Journal
Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review
Previous Article in Special Issue
The Prognostic and Predictive Utility of CDX2 in Colorectal Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette–Guérin Immunotherapy in Bladder Cancer Patients

1
Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore
2
School of Engineering, Biomedical Engineering, Temasek Polytechnic, Singapore 529757, Singapore
3
Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore
4
Department of Urology, Singapore General Hospital, Singapore 169608, Singapore
5
Division of Surgery & Surgical Oncology, National Cancer Center Singapore, Singapore 168583, Singapore
6
Department of Urology, National University Hospital, National University Health System, Singapore 119074, Singapore
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(16), 8947; https://doi.org/10.3390/ijms25168947
Submission received: 17 July 2024 / Revised: 11 August 2024 / Accepted: 13 August 2024 / Published: 16 August 2024

Abstract

Glutathione-S-transferases (GST) enzymes detoxify xenobiotics and are implicated in response to anticancer therapy. This study evaluated the association of GST theta 1 (GSTT1), GSTT2, and GSTT2B with Mycobacterium bovis Bacillus Calmette–Guérin (BCG) response in non-muscle-invasive bladder cancer treatment. In vitro assessments of GSTT2 knockout (KO) effects were performed using cell lines and dendritic cells (DCs) from GSTT2KO mice. Deletion of GSTT2B, GSTT1, and single-nucleotide polymorphisms in the promoter region of GSTT2 was analysed in patients (n = 205) and healthy controls (n = 150). Silencing GSTT2 expression in MGH cells (GSTT2BFL/FL) resulted in increased BCG survival (p < 0.05) and decreased cellular reactive oxygen species. In our population, there are 24.2% with GSTT2BDel/Del and 24.5% with GSTT2BFL/FL. With ≤ 8 instillations of BCG therapy (n = 51), 12.5% of GSTT2BDel/Del and 53.8% of GSTT2BFL/FL patients had a recurrence (p = 0.041). With ≥9 instillations (n = 153), the disease recurred in 45.5% of GSTT2BDel/Del and 50% of GSTT2BFL/FL. GSTT2FL/FL patients had an increased likelihood of recurrence post-BCG therapy (HR 5.5 [1.87–16.69] p < 0.002). DCs from GSTT2KO mice produced three-fold more IL6 than wild-type DCs, indicating a robust inflammatory response. To summarise, GSTT2BDel/Del patients respond better to less BCG therapy and could be candidates for a reduced surveillance regimen.
Keywords: glutathione S-transferase theta 2; polymorphism; genetic; BCG vaccine; urinary bladder neoplasms; bladder cancer; immunotherapy glutathione S-transferase theta 2; polymorphism; genetic; BCG vaccine; urinary bladder neoplasms; bladder cancer; immunotherapy

Share and Cite

MDPI and ACS Style

Rahmat, J.N.; Tham, S.M.; Ong, T.L.; Lim, Y.K.; Patwardhan, M.V.; Nee Mani, L.R.; Kamaraj, R.; Chan, Y.H.; Chong, T.W.; Chiong, E.; et al. Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette–Guérin Immunotherapy in Bladder Cancer Patients. Int. J. Mol. Sci. 2024, 25, 8947. https://doi.org/10.3390/ijms25168947

AMA Style

Rahmat JN, Tham SM, Ong TL, Lim YK, Patwardhan MV, Nee Mani LR, Kamaraj R, Chan YH, Chong TW, Chiong E, et al. Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette–Guérin Immunotherapy in Bladder Cancer Patients. International Journal of Molecular Sciences. 2024; 25(16):8947. https://doi.org/10.3390/ijms25168947

Chicago/Turabian Style

Rahmat, Juwita N., Sin Mun Tham, Ting Li Ong, Yew Koon Lim, Mugdha Vijay Patwardhan, Lata Raman Nee Mani, Revathi Kamaraj, Yiong Huak Chan, Tsung Wen Chong, Edmund Chiong, and et al. 2024. "Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette–Guérin Immunotherapy in Bladder Cancer Patients" International Journal of Molecular Sciences 25, no. 16: 8947. https://doi.org/10.3390/ijms25168947

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop